Physician
Psychiatry
Dr. John H. Heiligenstein, MD
|
|
Give Review
Doctor John H. Heiligenstein, MD is an expert in the field of Psychiatry. He attended University of Kentucky College of Medicine. University of Kentucky College of Medicine is ranked 63/72 in Research/PrimaryCare. John Heiligenstein is also a published MD. He has 38 paper published. The most recent paper is: Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.
Publications
- An exploratory factor analysis of the children's depression rating scale-revised.
- Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-2...
- Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents.
- Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study.
- Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder.
- AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology.
- The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration.
- Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placeb...
- Cardiovascular effects of atomoxetine in children, adolescents, and adults.
- Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.
- Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder.
- Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperact...
- Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.
- Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.
- The double-blind variable placebo lead-in period: results from two antidepressant clinical trials.
- An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder.
- Recovery from depression, work productivity, and health care costs among primary care patients.
- Long-term outcomes of initial antidepressant drug choice in a "real world" randomized trial.
- SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis.
- Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.
- A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.
- Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.
- Fluoxetine versus tricyclic antidepressants: a prospective multicenter study of antidepressant drug overdoses. The Antidepressant Study Group.
- Acute medical costs of fluoxetine versus tricyclic antidepressants. A prospective multicentre study of antidepressant drug overdoses.
- Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants.
- Is there a relationship between baseline and treatment-associated changes in 3H-IMI platelet binding and clinical response in major depression?
- Acute effects of fluoxetine versus placebo on functional health and well-being in late-life depression.
- A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group.
- Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: a comparative trial of fluoxetine versus imipramine.
- Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients.
- Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo.
- Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
- Fluoxetine not associated with increased aggression in controlled clinical trials.
- A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia.
- Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
- Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine.
- Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.
Schools
Loyola University of Chicago Stritch School of Medicine
Doctors Specialties
- Pediatric Psychiatry
- Psychiatry
Accepted Insurances
Education
-
University of Virginia -
University of Kentucky College of Medicine -
Loyola University Chicago Stritch School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Jason O. Mensah, DO |
|
|
Dr. Maria C. Poor, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Ann M. Kledzik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine Gilkey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carla A. Kilgore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth C. Berger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susanne Blix, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth A. Cunningham, DO |
|
|
Dr. Sheryl E. Sweeney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melisa Y. Martinez, MD |
|
|
Dr. Amit Anand, MD |
|
|
Dr. Douglas R. Cook, MD |
|
|
Dr. Raul R. Burciaga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul S. Taraska, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth L. Smith II, DO |